Current Health News: ACA Enrollment, New Weight-loss Drugs, and More

A summary of the latest health news, including ACA enrollment stats, future weight-loss treatments, calls for hospital security in Italy, a pesto botulism scare in France, insider trading at Ipsen, a breakthrough in thyroid eye disease treatment, opioid settlement in Baltimore, polio vaccination in Gaza, Teva facing an EU fine, and changes in drug reimbursement by UnitedHealth.

The U.S. Department of the Treasury reported that over 49 million Americans have gained coverage through ACA marketplaces since 2014, with peak enrollment at 20.8 million in 2024.

Analysts predict the weight-loss treatment market will see 16 new drugs by 2029, potentially reaching $200 billion by 2031. Italy's health workers demand increased hospital security after recent assaults. France investigates five likely botulism cases linked to contaminated pesto sauce. Ipsen employee Dishant Gupta plans to plead guilty to insider trading.

Viridian Therapeutics' new drug shows promise treating thyroid eye disease. Baltimore reaches a $402.5 million opioid settlement with Walgreens and Teva. Despite obstacles, polio vaccination advances in north Gaza. Teva faces an impending EU antitrust fine for anti-competitive practices. UnitedHealth will exclude AbbVie's Humira from some reimbursement lists in favor of biosimilars.

(With inputs from agencies.)